Critical Metals Corp. (CRML) focuses on lithium and rare earth elements with projects in Austria and Greenland, while NioCorp Developments Ltd. (NB) targets niobium, scandium, and titanium at its Elk Creek project in Nebraska. Both companies operate in the critical minerals sector, exposing them to similar macroeconomic drivers such as electrification demand and supply chain diversification.

RDCM has held near the $10 level over the past 30 days, roughly flat after a sharp July selloff triggered by a cut to full-year revenue guidance. Second-quarter 2026 revenue declined 33.4% year over year to $11.8 million as customer deployments were delayed by component-cost and supply constraints.

Both CRML and USAR operate in the critical minerals and rare earths sector, with exposure to lithium, heavy rare earth elements, and materials essential for electrification and defense applications. Recent market activity shows elevated volatility for both stocks, driven by project updates and sector-wide interest in domestic supply chains amid global competition for rare earth processing.

The selected price objective is $8.00 , roughly 40% above recent trading levels and well beyond the stock's 52-week high of approximately $6.25. The strongest bullish case rests on a growing defense backlog, including work tied to the U.S. Navy submarine program, and recovering revenue momentum.

NVOX, the 2x leveraged long Novo Nordisk ADR ETF, fell -16.20% to about $10.40 during Monday's regular session, roughly doubling the underlying NVO's ~-7% slide. The primary catalyst: Novo Nordisk's Capital Markets Day targets underwhelmed, reiterating a ~$23 billion obesity/pipeline sales goal rather than raising it, while guiding 2026–30 revenue growth only in line with peers.

QNME is trading down about -10.34% during Monday's regular session, near $0.50, versus Friday's $0.5583 close. The pullback is a giveback of Friday's +92.25% spike, when shares surged to $0.5583 (intraday high $1.03) on roughly 328M shares with multiple volatility trading halts.

RKLZ is down -13.47% intraday during regular market hours, sliding from $19.08 to $16.51. The move is mechanical: RKLZ is a 2x inverse ETF, so it falls when underlying Rocket Lab (RKLB) rallies.

MSTZ fell -15.25% to $2.39, down -$0.43 from Friday's $2.82 close, sliding in premarket and extending the loss into the regular session. As a -2x daily inverse of MicroStrategy (MSTR), MSTZ moves opposite MSTR; MSTR jumped about +7.4% premarket, mechanically pressuring the ETF.

DAMD is down -17.92% today, falling from a prior close of $11.05 to roughly $9.07 during the regular trading session. The decline is driven by a sharp rally in its underlying reference asset, AMD, which surged to record highs and pushed its market cap toward $1 trillion.

AXTQ fell -32.37% intraday during regular market hours, dropping from $32.56 to about $22.02. The drop is mechanical: AXTQ is a -2x daily inverse ETF that moves opposite to AXT Inc. (AXTI), so it slides when AXTI rallies.

CUE is down -27.45% in the regular session, trading near $26.88 versus Friday's close of $37.05. The stock initially spiked roughly +41% premarket after positive Phase 2 CUE-221 results in chronic spontaneous urticaria (primary and key secondary endpoints met).

DLXY fell -29.07% to about $0.61 in Monday's regular session, down from Friday's close of $0.86. The slide followed the company's announcement of a 1-for-5 reverse stock split effective Sept 28, 2026.

SPCH is a leveraged single-stock ETF seeking twice (2X) the daily return of SpaceX (traded as SPCX ); it recently traded near $9.87, far below its $28.01 52-week high. A move to $15 would require a gain of roughly 50% and sits within a technical retracement zone between the fund's launch high and its $5.30 low.

MSTR is up +8.76% to about $167.40 in Monday's regular session, extending a sharp premarket gain after Friday's +16.39% surge. Primary catalyst: an 8-K filing showed Strategy bought 950 bitcoin and repurchased ~1.77M STRC preferred shares last week, while Saylor's Sunday "a little more orange" post teased a resumed accumulation.

AMD is up +7.24% to roughly $600.37 in the regular session, versus a prior close of $559.82. The advance followed premarket gains of about +3%, extending higher into market hours.

CRML (Critical Metals Corp) is up roughly +34.62%, trading near $9.06 versus Friday's close of $6.73. The move began in premarket trading and extended into the regular session Monday.

INTC is up +7.69% intraday to roughly $116.95, extending gains that began with a ~5–6% premarket surge after last week's breakout. The move is occurring during regular market hours, building on premarket strength.

META gained +5.09% to about $699.63 during Monday's regular session, building on a ~3% premarket advance. Primary catalyst: Wells Fargo raised its price target to $796 (from $640), extending a wave of bullish AI-driven analyst calls.

TPB fell -9.64% to about $61.57 during regular trading on Sept. 21, 2026, versus the prior close of $68.14. The drop followed the morning announcement that CEO Graham Purdy is stepping down Oct. 1 for personal reasons, with Executive Chairman David Glazek named as his successor.

MasTec shares declined roughly 21.2% over the last 30 days, falling from $272.07 on August 19, 2026, to a latest close of $214.38. The pullback extends a broader slide, with the stock down more than 40% over the trailing three-month period.